| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |